[go: up one dir, main page]

Chung et al., 1996 - Google Patents

Factors that control extravascular fibrinolysis

Chung et al., 1996

Document ID
8954089369916355432
Author
Chung S
Lee S
Uchino R
Carmassi F
Publication year
Publication venue
Seminars in thrombosis and hemostasis

External Links

Snippet

The physiological and pathophysiological state of tissues determines the exudation of plasma proteins, hemostasis, and fibrinolysis, ie, inflammation, injury, and malignancy. The physiological controls of extravascular fibrinolysis ultimately rest on a balance between …
Continue reading at www.thieme-connect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/484—Plasmin (3.4.21.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans

Similar Documents

Publication Publication Date Title
Weisel et al. The biochemical and physical process of fibrinolysis and effects of clot structure and stability on the lysis rate
Chapin et al. Fibrinolysis and the control of blood coagulation
Nyberg et al. Endogenous inhibitors of angiogenesis
Daly et al. Hemostatic regulators of tumor angiogenesis: a source of antiangiogenic agents for cancer treatment?
Esmon et al. Inflammation, sepsis, and coagulation
Simon et al. Fibrin (ogen) is internalized and degraded by activated human monocytoid cells via Mac-1 (CD11b/CD18): a nonplasmin fibrinolytic pathway
Kwon et al. S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors
Nicholl et al. Plasminogen activator system and vascular disease
Falanga et al. Pathogenesis of thrombosis in patients with malignancy
Mazar et al. The urokinase plasminogen activator system in cancer: implications for tumor angiogenesis and metastasis
Cesarman‐Maus et al. Molecular mechanisms of fibrinolysis
Collen et al. Influence of fibrin structure on the formation and maintenance of capillary-like tubules by human microvascular endothelial cells
Bini et al. Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): hydrolysis of the γ Gly 404− Ala 405 peptide bond
Urech et al. Mechanical properties, proteolytic degradability and biological modifications affect angiogenic process extension into native and modified fibrin matrices in vitro
Gordon Cancer cell procoagulants and their role in malignant disease
Tallman et al. New insights into the pathogenesis of coagulation dysfunction in acute promyelocytic leukemia
Kost et al. Limited plasmin proteolysis of vitronectin: characterization of the adhesion protein as morpho‐regulatory and angiostatin‐binding factor
Idell et al. Fibrin turnover in lung inflammation and neoplasia
Schoppet et al. Molecular interactions and functional interference between vitronectin and transforming growth factor-β
Conway et al. Biologically active thrombomodulin is synthesized by adherent synovial fluid cells and is elevated in synovial fluid of patients with rheumatoid arthritis
Kluft t-PA in fibrin dissolution and hemostasis
Matsuzaki et al. Sivelestat reduces inflammatory mediators and preserves neutrophil deformability during simulated extracorporeal circulation
Hess et al. The versatility of adhesion receptor ligands in haemostasis: morpho-regulatory functions of vitronectin
Chung et al. Factors that control extravascular fibrinolysis
Engelholm et al. The urokinase receptor associated protein (uPARAP/endo180): a novel internalization receptor connected to the plasminogen activation system